Paid Clinical Trials Nebraska
Discover 571 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Chyme Reinfusion for Type 2 Intestinal FailureChyme Reinfusion for Type 2 Intestinal Failure
Sponsor:
Databean
Location:
Code:
NCT04577456
Conditions
Intestinal Failure
Enterocutaneous Fistula
Ileostomy - Stoma
High Output Stoma
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
The Insides System
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
MPH HCl EREfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
Sponsor:
Ironshore Pharmaceuticals and Development, Inc
Location:
Code:
NCT06431256
Conditions
Attention Deficit Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 4 - 5
Healthy Volunteers: Not accepted
Interventions
HLD200 methylphenidate hydrochloride capsules
Placebo HLD200 capsules
ELANA 841PAT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal
Sponsor:
Carl Zeiss Meditec, Inc.
Location:
Code:
NCT06264232
Conditions
Cataract Senile
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Cataract Surgery
ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
TeneoOne Inc.
Location:
Code:
NCT05650632
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-383
Interested in new trials?
Get alerts for new trials in your area by subscribing now
WATER IVWATER IV Prostate Cancer
Sponsor:
PROCEPT BioRobotics
Location:
Code:
NCT06651632
Conditions
Localized Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Aquablation Therapy
Radical Prostatectomy
AnifrolumabA 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Sponsor:
AstraZeneca
Location:
Code:
NCT06015737
Conditions
Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Anifrolumab
Placebo
Lumbar PunctureThe Effectiveness of a Pediatric Lumbar Puncture Restraint Device
Sponsor:
University of Nebraska
Location:
Code:
NCT00980070
Conditions
Indication for Lumbar Puncture
Eligibility Criteria
Sex: All
Age: 1 - 70+
Healthy Volunteers: Not accepted
Interventions
Pediatric Restraint for Lumbar Puncture
Lumbar Puncture Device
Standard of Care
Venetoclax with cBTKiA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.
Sponsor:
Genentech, Inc.
Location:
Code:
NCT06524375
Conditions
Chronic Lymphocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Venetoclax
cBTKi Monotherapy
Observational StudyAn INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY to ASSESS the PERFORMANCE of the CORDIO HEARO SYSTEM
Sponsor:
Cordio Medical
Location:
Code:
NCT06378632
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Hearo App